Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery
© 2020 Wiley Periodicals, Inc..
AIM: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put health care workers at risk when exposed to aerosolized viral particles during upper airway mucosal surgery. The objective of this review was to discuss topical preparations that could be utilized preoperatively to help to decrease viral load and potentially reduce the risks of viral transmission.
METHODS: A PubMed/MEDLINE database review of articles was performed querying topical preparations with virucidal activity against coronaviruses.
RESULTS: Povidone-iodine (PVP-I) solutions ranging from 0.23% to 7% have been found to demonstrate highly effective virucidal activity against a broad range of viruses including several coronaviruses responsible for recent epidemics including SARS-CoV-1 and MERS-CoV.
CONCLUSIONS: While specific evidence regarding SARS-CoV-2 is lacking, PVP-I-based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS-CoV-2 aerosolization during upper airway mucosal surgery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Head & neck - 42(2020), 6 vom: 20. Juni, Seite 1268-1272 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parhar, Harman S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aerosols |
|---|
| Anmerkungen: |
Date Completed 08.06.2020 Date Revised 18.12.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/hed.26200 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309177278 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309177278 | ||
| 003 | DE-627 | ||
| 005 | 20231225133332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hed.26200 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1030.xml |
| 035 | |a (DE-627)NLM309177278 | ||
| 035 | |a (NLM)32333619 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parhar, Harman S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals, Inc. | ||
| 520 | |a AIM: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put health care workers at risk when exposed to aerosolized viral particles during upper airway mucosal surgery. The objective of this review was to discuss topical preparations that could be utilized preoperatively to help to decrease viral load and potentially reduce the risks of viral transmission | ||
| 520 | |a METHODS: A PubMed/MEDLINE database review of articles was performed querying topical preparations with virucidal activity against coronaviruses | ||
| 520 | |a RESULTS: Povidone-iodine (PVP-I) solutions ranging from 0.23% to 7% have been found to demonstrate highly effective virucidal activity against a broad range of viruses including several coronaviruses responsible for recent epidemics including SARS-CoV-1 and MERS-CoV | ||
| 520 | |a CONCLUSIONS: While specific evidence regarding SARS-CoV-2 is lacking, PVP-I-based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS-CoV-2 aerosolization during upper airway mucosal surgery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a head and neck cancer | |
| 650 | 4 | |a safety | |
| 650 | 7 | |a Aerosols |2 NLM | |
| 650 | 7 | |a Anti-Infective Agents, Local |2 NLM | |
| 700 | 1 | |a Tasche, Kendall |e verfasserin |4 aut | |
| 700 | 1 | |a Brody, Robert M |e verfasserin |4 aut | |
| 700 | 1 | |a Weinstein, Gregory S |e verfasserin |4 aut | |
| 700 | 1 | |a O'Malley, Bert W |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Shanti, Rabie M |e verfasserin |4 aut | |
| 700 | 1 | |a Newman, Jason G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 42(2020), 6 vom: 20. Juni, Seite 1268-1272 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2020 |g number:6 |g day:20 |g month:06 |g pages:1268-1272 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/hed.26200 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2020 |e 6 |b 20 |c 06 |h 1268-1272 | ||